Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Aldesleukin
(Recombinant human interleukin-2) | [4] ALDESLEUKIN ALDESLEUKIN; ILT-101; Proleukin; Recombinant human interleukin-2 | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA,IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [6] 2 2, 35, 49, 65, 96, 97 💬
|
| 2 | Human interleukin-2 | [3] Human interleukin-2 Human interleukin-2; IL-2; INTERLEUKIN-2 | - | - | - | [18] 2 2, 13, 35, 46, 49, 50, 51, 53, 55, 56, 60, 63, 65, 95, 96, 97, 162, 271 💬
|